PLOD2 and hepatocellular carcinoma: The results revealed that CHP1 had low expression and PPIA, ALG3, CTSA, CAD, B3GAT3, TRAPPC3, HSP90AA1, SRD5A3, BAG2, DNAJC1, ADAMTS5, PLOD2, DYNC1LI1, and ST6GALNAC4 were significantly overexpressed in human hepatocellular carcinoma cells compared to MIHA (Figure 2A).